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Abstract 
Saponins are extensively known for many biological activities e.g. antimicrobial, anti-
palatability, anti-cancer and hemolytic. As cancer cells have a more cholesterol-like compound 
in their membrane structure the saponins bind cholesterol due to their natural affinity to bind 
cancer cell membrane. This prevents them from entering the body through the intestinal tract 
where they have the ability to attach themselves to vital organs and grow. This study reports the 
effective use of lower dose saponins like immunotoxin so that they can inhibit the proliferation 
of cancerous pancreatic cells. The investigation of pancreatic cancer metabolic pathway it was 
found that proteins 3H3B produced by genes HER-2 are involved in the enhancement of this 
type of cancer. Further docking studies showed that there is an effective interaction between 
saponins and cancer cells. The glide score of the saponin analogue compound with CID 
21573770 (Pubchem) was -6.30 followed by score of -6.05 and -5.29 for 5-Florouracil and 
gemcitabine respectively. The interaction was observed in the GLU and GLN rich region, 
saponins made H-bonds with GLU-188, GLN-119, VAL-72 and GLN-71. This study indicates 
an effective way towards leading newer prospects for developing saponin analogue based cancer-
fighting drugs with improved cancer cell inhibition property without killing normal cells. 
Keywords:  Saponins, molecular docking, anti cancer, pancreatic cancer, Solanum tuberosum 
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1. Introduction 
Pancreatic cancer is a malignant abnormal proliferation of the pancreas. The percentage of 
developing pancreatic cancer in our lifetime is about 1 in 71(1.41%) it is same for men and 
women. Risk factor alters by factor like age, gender, race, smoking, diabetes etc. [1],[2], [3]. The 
rate of survival of patient suffering from pancreatic cancer is less as compared to other cancers 
(Government cancer report). There are drugs already available for pancreatic cancer but they all 
show a lot of side effects. Since during the cancer, patient is already suffering from many 
problems, so most patient are unable to tolerate the side effect of chemotherapy [4]. In this study 
we have selected saponins from Solanum tuberosum and its similar structures retrieved from 
Pubchem which was further compared with available drug i.e. 5-Florouracil and Gemcitabine. 
Saponins are micro-compound they can be obtained from different sources, each structure 
obtained from different source is having different structure and they differ in their mechanism 
too. Around 53 families of plant produce saponins and the number of species is much higher [5]. 
They are surface active compound which are not observed, they also change the morphology and 
permeability of cells. Saponins are involved in the normalization of carcinogenic cell 
proliferation and induce several immune responses rather than a single one. Saponin from 
soybean is effective for colon cancer [6]. Saponin from different sources differs slightly as it is 
shown in the saponins from M.sativa and M. truncatula mainly difference found in the more 
polar region. M.sativa and M. truncatula both possess (1→3) specific glucosyltransferase but 
M.sativa possesses (1→2) specific glucosyltransferase [7]. 
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2. Material and Methods 
Saponins from Solanum tuberosum with its similar structure (20 structures) of around 90% 
similarity was retrieved from Pubchem database (http://pubchem.ncbi.nlm.nih.gov/). Pathway 
was studied in pancreatic cancer from KEGG (http://www.genome.jp/kegg/) (Figure 1) the over 
expression of HER-2 [8] and point mutations in the K-ras gene was affecting the normal pathway 
and enhances carcinogenic probability. 
Structure of HER-2 (PDB ID 3H3B) was downloaded from Protein Data Bank 
(http://www.pdb.org/) Docking was performed with GLIDE 8.5. First the preparation of protein 
as well as of all the legand was done and their energies were minimized. As a reference molecule 
we have taken 5-Fu and gemcitabine, we compared the result of these drugs with saponins and 
its similar structure. The docking we did was flexible docking and with default parameters set. 
3. Result and Discussion 
5-Florouracil (5-Fu) is the drug which is being used from the beginning for the treatment of 
pancreatic cancer but it showed some side effects for example it induces cardiotoxicity and is 
responsible for dihydropyrimidine dehydrogenase (DPYD) gene germline mutation [9]. In a 
study conducted 5-Florouracil along with folinic acid and interferon α-2a (IFN- α) has shown no 
tumor progression in the first two months, it was tested in the 77% of total patient taken under 
the trial [4]. A similar kind of test was performed by combination of gemcitabine with 5-
Florouracil and folinic acid which proved to have a low toxicity profile, this result has been 
shown by testing the combination of gemcitabine with 6 different forms of 5-Florouracil [10]. 5-
Fu/FA/IFN- α combination prevented tumor progression initially and it was unclear that whether 
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it has positive effect or advantage over 5-Fu alone or with combination with Fu but according to 
recent studies when the combination of 5-Fu and FA [11]) was given to a patient they resulted 
effective as compared to gemcitabine. We noted that saponins help to eliminate tumor cells by 
apoptosis, according to a detailed study of the structure of saponins, sugar side chain influence 
the tumor cells and with study of all other side chains a results was observed in favour of saponin  
[12]. We compared the result of 5-Fu and gemcitabine with saponins and their relative structures. 
It was done on the basis of GLIDE scores. The compound with CID 21573770 (Fig 2a) of 
pubchem shown the best result i.e. -6.30 followed by the score of 5-Florouracil(-6.05) and 
gemcitabine (-5.29). CID 21573770 is having molecular weight 868.05882 [g/mol] and its 
molecular formula is C45H73NO15. The interaction between saponins was observed to be in the 
GLU and GLN rich region, saponins made H-bonds with GLU-188, GLN-119, VAL-72 and 
GLN-71 making it as an effective interaction.  
With this interaction conclusion may refer to have saponins to be more interactive with other two 
drugs. Since last 12 years gemcitabine is being used over 5-Florouracil because it possesses 
manageable toxic effects and used as a medical standard for pancreatic cancer [13]. Saponins is 
showing better results than gemcitabine, though it has been shown in just one respect, further 
research can prove it to be an effective and non toxicity drug for pancreatic cancer. As stated 
above a large family of plant produces saponins but saponins biosynthesis in all the family does 
not depend on the plant order. There are 11 main skeletons identified on which different 
functional groups and sugar chains are attached to make it individual [14].There are many 
insilico methods like metabolic pathway study or creation through which effective drug target 
can be identified and can benefit in the drug discovery process [15]. 
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4. Conclusion 
In the present study we have targeted a single protein HER2 (PDB ID: 3H3B) which is 
responsible for the enhancement of tumor cell growth. Saponins a secondary metabolite of plants 
came out to be an efficient chemicals with capability of inhibiting tumor cells. Similarly we can 
study other targets with study of metabolic pathways and can find most crucial target. Creation 
of analogs of saponins and screening it on a large scale may provide a promising drug which will 
bring the quality of life for pancreatic patient. Since many drugs are not permitted through the 
cell membrane and them posses some other drawbacks, ADME studies can be done with some 
selective screened drugs.  Nevertheless the present docking studies are limited only to certain 
saponin based analogues but they significantly guide towards new insilico approaches in 
development of cancer-fighting drugs with improved cancer cell inhibition property  
Acknowledgement: The authors gratefully acknowledge the Government of Jharkhand, 
Department of Agriculture for providing infrastructure development fund to our department. 
Authors duly acknowledge DBT, Govt. of India for providing BTIS Sub DIC facility for our 
department. 
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Figure Captions 
Figure 1. Pathway showing gene enhancing (HER2) the cancer and how it is doing. Source 
(http://www.genome.jp/kegg/). 
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Figure 2. Chemical structures of drugs used for the treatment of Pancreatic cancer              
(a)CID 21573770, (b) gemcitabine, (c) 5-Florouracil. 
  
 
Compound ID(CID)  
 21573770 
Compound ID  (CID)  
60750 (gemcitabine) 
Compound ID(CID) 
 3855(Fluorouracil) 
Molecular Formula 
C45H73NO15 
Molecular Formula 
C9H11F2N3O4 
Molecular Formula 
C4H3FN2O2 
Molecular Weight 
868.05882 [g/mol] 
Molecular Weight 
263.198146 [g/mol] 
Molecular Weight 
130.077223 [g/mol] 
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Figure 3. Interaction of HER2 protein with saponins from Solanum tuberosum. H-bonds are 
formed between GLU-188, GLN-119, VAL-72 and GLN-71 and the protein HER2. 
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